Physician profile
Matthew Mitchell
NPI 1780671842
$4,523.42
in general payments reported to CMS, 2019-2025
25 companies · $359 in 2025
The $359 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $1,845 · 2021: $700 · 2022: $176 · 2023: $379 · 2024: $461 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,716.26 | 2019-2023 | Proclaim, Eterna, Eon C |
| Nevro Corp. | $272.91 | 2019-2024 | Senza |
| Medtronic USA, INC. | $257.83 | 2019-2020 | |
| Boston Scientific Corporation | $229.79 | 2019-2025 | Intracept |
| Pacira Pharmaceuticals Incorporated | $216.91 | 2021-2024 | Exparel |
| Medtronic, INC. | $150.46 | 2021-2025 | Intellis Adaptivestim, Accurian |
| Saluda Medical Americas, INC. | $127.96 | 2024-2025 | Evoke |
| Biotronik Nro, INC. | $121.82 | 2025 | Prospera |
| Globus Medical, INC. | $50.07 | 2025 | Vyrsa V1, Senza |
| Ibsa Pharma INC. | $40.62 | 2021 | |
| Spinal Simplicity, LLC | $39.19 | 2024 | Ha Minuteman G3-R |
| Assertio Therapeutics, INC. | $36.90 | 2019 | |
| Valinor Pharma, LLC | $34.50 | 2024 | Movantik |
| Acacia Pharma INC | $32.87 | 2021-2022 | |
| Averitas Pharma INC. | $24.21 | 2023 | Qutenza |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $23.96 | 2022 | |
| Redhill Biopharma INC. | $21.65 | 2021 | |
| Almatica Pharma LLC | $18.28 | 2021 | |
| Collegium Pharmaceutical, INC. | $17.48 | 2019 | |
| Stryker Corporation | $16.68 | 2020 | |
| Merz North America, INC. | $16.65 | 2020 | |
| Daiichi Sankyo INC. | $16.41 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.26 | 2025 | Relistor |
| Stimwave Technologies Incorporated | $12.99 | 2020 | |
| Si-Bone, INC. | $10.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.